SCHEMBL21362565

SCHEMBL21362565

CCSCc1ccc(C(=O)c2ccc(F)cc2CC)c(Br)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
LMNA P02545 4/20 0.36
TP53 P04637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
F2R P25116 1/20 0.35
ALDH1A1 P00352 3/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
PTPN1 P18031 1/20 0.32
RAB9A P51151 2/20 0.32
XBP1 P17861 1/20 0.32
HIF1A Q16665 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157570 0.89 CES2 (0.41) HTTF2RALDH1A1GAAKMT2A
SCHEMBL20157770 0.88 ALDH1A1 (0.36) MAPTTP53F2RALDH1A1GAA
SCHEMBL20157580 0.85 LMNA (0.37) MAPTLMNATP53KDM4EALOX15
SCHEMBL20157850 0.84 MAPT (0.39) MAPTLMNATP53KDM4EALOX15
SCHEMBL21564973 0.81 CCNB2 (0.33) TP53KDM4EHTTF2RALDH1A1
SCHEMBL20157817 0.80 MAOB (0.38) MAPTLMNAALDH1A1GAAKMT2A
SCHEMBL21564964 0.79 PTPRC (0.34) MAPTLMNATP53F2RALDH1A1
SCHEMBL5188661 0.78 CES2 (0.47) MAPTLMNATP53KDM4EALOX15
SCHEMBL21564818 0.77 SMN1; SMN2 (0.43) MAPTKDM4EMAPK1HTTHSD17B10
SCHEMBL20158143 0.77 LCK (0.37) MAPTLMNAKDM4EHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed